Share Price | Dolphin Medical Services Ltd Stock Analysis & Recommendation

Q: Is Dolphin Medical overvalued or undervalued?

As of 12 November 2024, Dolphin Medical's valuation grade has moved from does not qualify to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued based on its current financial ratios, which include a PE ratio of -3.58, an EV to EBITDA of -4.38, and a Price to Book Value of 0.35. These figures suggest that the company is struggling to generate positive earnings and is not effectively utilizing its assets.When compared to its peers, Dolphin Medical's financial metrics starkly contrast with those of Max Healthcare, which has a PE ratio of 100.29, and Apollo Hospitals, with a PE ratio of 69.03. This highlights the significant gap in valuation and operational performance within the healthcare services sector. Additionally, Dolphin Medical's recent stock performance has lagged behind the Sensex, with a 1-week return of -3.36%, further reinforcing the notion that the company is currently overvalued in the market.

Q: What is the technical trend for Dolphin Medical?

As of 21 January 2025, the technical trend for Dolphin Medical has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD remains bullish. The daily moving averages show a mildly bullish trend, suggesting some short-term strength. However, the weekly Bollinger Bands are bearish, which adds caution. The KST and OBV on a monthly basis are both bullish, supporting the mildly bullish outlook. Overall, the current technical stance is mildly bullish, driven primarily by the daily moving averages and monthly indicators.

Q: What does Dolphin Medical do?

Overview: Dolphin Medical Services Ltd operates in the healthcare services industry and is categorized as a micro-cap company.History: Dolphin Medical Services Limited was established in September 1992 and is promoted by doctors from the coastal region of Andhra Pradesh. The latest quarterly results reported are for March 2025, showing net sales and profit figures.Financial Snapshot: Most recent Net Sales: 1 Cr (Quarterly Results - Mar 2025) Most recent Net Profit: -1 Cr (Quarterly Results - Mar 2025) Market-cap value: INR 3 Cr (Micro Cap)Key Metrics: P/E: N/A Industry P/E: 81 Dividend Yield: 0.00% Debt-Equity: 0.08 Return on Equity: -1.67% Price to Book: 0.32Contact Details: Address: # No 417 Sanali Heavens, Ameerpet Hyderabad Telangana : 500073 Tel: 91-040-23738877 Email: dolphinmedicalindia@gmail.com Website: http://www.dolphinmedicalservices.com

Q: Who are the top shareholders of the Dolphin Medical?

The top shareholders of Dolphin Medical include G V Mohan Prasad, who holds the highest stake at 12.71%. The highest public shareholder is Manish Ramanlal Shah, with a holding of 1.68%. Additionally, individual investors collectively hold a significant portion of the company, accounting for 69.81% of the shares. There are no institutional holdings or pledged promoter holdings reported.

Upcoming Result: Dolphin Medical will declare its result soon on 30 Jan 2026

52-Week High: Rs.3.28 hit today

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.31 lacs (222.46%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

26.44%

Is Dolphin Medical overvalued or undervalued?

09-Jun-2025

As of November 12, 2024, Dolphin Medical's valuation has deteriorated to "risky," with negative financial ratios indicating overvaluation and poor performance compared to peers like Max Healthcare and Apollo Hospitals, alongside a recent stock decline of 3.36%.

View full answer

What is the technical trend for Dolphin Medical?

09-Jun-2025

As of January 21, 2025, Dolphin Medical's technical trend is mildly bullish, supported by daily moving averages and monthly indicators, despite some bearish signals from the weekly MACD and Bollinger Bands.

View full answer

Who are in the management team of Dolphin Medical?

16-Jul-2025

As of March 2020, the management team of Dolphin Medical includes G V Mohan Prasad (Managing Director & CEO), M Lakshmi Sudha (Whole Time Director & CFO), and five non-executive directors: Vinay Vishnuraj Nayak, Narendra Seena Karkera, K Ramana Kumar, along with executive directors Nanapaneni Buddha Sagar and Madala Sesha Ratnam.

View full answer

What does Dolphin Medical do?

17-Jul-2025

Dolphin Medical Services Ltd is a micro-cap healthcare company established in 1992, primarily operated by doctors from Andhra Pradesh. As of March 2025, it reported net sales of 1 Cr and a net loss of 1 Cr, with a market cap of INR 3 Cr.

View full answer

Who are the top shareholders of the Dolphin Medical?

17-Jul-2025

The top shareholder of Dolphin Medical is G V Mohan Prasad, with a 12.71% stake, followed by public shareholder Manish Ramanlal Shah at 1.68%. Individual investors hold a combined 69.81% of the shares, with no institutional or pledged promoter holdings reported.

View full answer

Which are the latest news on Dolphin Medical?

19-Jan-2026

No latest news for Dolphin Medical found.

When is the next results date for Dolphin Medical?

19-Jan-2026

The next results date for Dolphin Medical is January 30, 2026.

View full answer

Why is Dolphin Medical falling/rising?

19-Jan-2026

As of 19-Jan, Dolphin Medical Services Ltd's stock price is at 3.10, down 0.96% due to decreased investor participation and a recent drop in trading volume. Despite this short-term decline, the stock has shown strong year-to-date and annual performance, indicating a generally positive long-term trend.

View full answer

Compare Dolphin Medical with Similar Stocks

Ashram Online Boston Bio Looks Health

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Healthcare Services

Market cap

INR 5 Cr (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.08

Return on Equity

-0.10%

Price to Book

0.47

Revenue and Profits:

Net Sales:

0 Cr

(Quarterly Results - Sep 2025)

Net Profit:

0 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

49.04%

6 Months

35.37%

1 Year

16.54%

2 Years

0.0%

3 Years

70.33%

4 Years

-2.82%

5 Years

85.63%

Dolphin Medical for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

When is the next results date for Dolphin Medical?

The next results date for Dolphin Medical is scheduled for January 30, 2026....

Read full news article

Announcements

Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025

16-Jan-2026 | Source : BSE

Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 inter alia to consider and approve Board meeting intimation

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

15-Jan-2026 | Source : BSE

Reg 74(5)

Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended Ended September 30 2025

11-Nov-2025 | Source : BSE

Unaudited Financial Results For The Quarter And Half Year Ended Ended September 30 2025

Corporate Actions

BOARD MEETING

30 Jan 2026

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

9.30%

EBIT Growth (5y)

6.50%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

-12.46%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.46

EV to EBIT

-5.48

EV to EBITDA

5.48

EV to Capital Employed

0.50

EV to Sales

5.48

PEG Ratio

Dividend Yield

ROCE (Latest)

-0.37%

ROE (Latest)

-0.10%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

G V Mohan Prasad (12.71%)

Highest Public shareholder

None

Individual Investors Holdings

69.81%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 5.88% vs 21.43% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is -66.67% vs 142.86% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.18",
          "val2": "0.17",
          "chgp": "5.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.03",
          "val2": "0.04",
          "chgp": "-25.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.01",
          "val2": "0.03",
          "chgp": "-66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.67%",
          "val2": "23.53%",
          "chgp": "-6.86%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -10.26% vs 14.71% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 33.33% vs 0.00% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.35",
          "val2": "0.39",
          "chgp": "-10.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.06",
          "val2": "0.03",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.04",
          "val2": "0.03",
          "chgp": "33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.14%",
          "val2": "7.69%",
          "chgp": "9.45%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Mar 2025 is -1.85% vs 1.89% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Mar 2025 is -233.33% vs 200.00% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.53",
          "val2": "0.54",
          "chgp": "-1.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.02",
          "val2": "0.05",
          "chgp": "-140.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.04",
          "val2": "0.03",
          "chgp": "-233.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3.77%",
          "val2": "9.26%",
          "chgp": "-13.03%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 14.71% vs 11.48% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 70.00% vs 16.67% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.78",
          "val2": "0.68",
          "chgp": "14.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.00",
          "val2": "-0.07",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.01",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.03",
          "val2": "-0.10",
          "chgp": "70.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-10.29%",
          "chgp": "10.29%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Sep'25

Jun'25

Change(%)

Net Sales

0.18

0.17

5.88%

Operating Profit (PBDIT) excl Other Income

0.03

0.04

-25.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

0.01

0.03

-66.67%

Operating Profit Margin (Excl OI)

16.67%

23.53%

-6.86%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2025 is 5.88% vs 21.43% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is -66.67% vs 142.86% in Jun 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

0.35

0.39

-10.26%

Operating Profit (PBDIT) excl Other Income

0.06

0.03

100.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

0.04

0.03

33.33%

Operating Profit Margin (Excl OI)

17.14%

7.69%

9.45%

Values in Rs Cr.

Compare with Peers

Net Sales

Growth in half year ended Sep 2025 is -10.26% vs 14.71% in Sep 2024

Standalone Net Profit

Growth in half year ended Sep 2025 is 33.33% vs 0.00% in Sep 2024

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Mar'25

Mar'25

Dec'23

Change(%)

Net Sales

0.53

0.54

-1.85%

Operating Profit (PBDIT) excl Other Income

-0.02

0.05

-140.00%

Interest

0.00

Exceptional Items

0.00

Standalone Net Profit

-0.04

0.03

-233.33%

Operating Profit Margin (Excl OI)

-3.77%

9.26%

-13.03%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in nine months ended Mar 2025 is -1.85% vs 1.89% in Dec 2023

Standalone Net Profit

YoY Growth in nine months ended Mar 2025 is -233.33% vs 200.00% in Dec 2023

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

0.78

0.68

14.71%

Operating Profit (PBDIT) excl Other Income

0.00

-0.07

100.00%

Interest

0.01

Exceptional Items

0.00

Standalone Net Profit

-0.03

-0.10

70.00%

Operating Profit Margin (Excl OI)

0.00%

-10.29%

10.29%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 14.71% vs 11.48% in Mar 2024

Standalone Net Profit

YoY Growth in year ended Mar 2025 is 70.00% vs 16.67% in Mar 2024

All Annual Results

Company CV

About Dolphin Medical Services Ltd

Dolphin Medical Services Ltd

Small Cap

Healthcare Services

Dolphin Medical Services Limited, established in September, 1992 is an organization promoted by the doctors from the coastal region of Andhra Pradesh. The Chief Promoters are Dr. M. S. S. Koteswara Rao, an eminent physician and former Minister for Health in Andhra Pradesh and Dr. G. V. Mohan Prasad, a Radiologist cum ENT specialist is the Managing Director of the Company.

Company Coordinates

Company Details

# No 417 Sanali Heavens, Ameerpet Hyderabad Telangana : 500073

Tel: 91-040-23738877

http://www.dolphinmedicalservices.com

dolphinmedicalindia@gmail.com

Registrar Details

XL Softech Systems Ltd , 3 Sagar Society Road , No 2 Banjara Hills, Hyderabad

Dolphin Medical

1Day

52 Week

CASH

FII

DII

Promoter

Is Dolphin Medical overvalued or undervalued?

Watch in Real-Time

What is the technical trend for Dolphin Medical?

Who are in the management team of Dolphin Medical?

What does Dolphin Medical do?

Who are the top shareholders of the Dolphin Medical?

Which are the latest news on Dolphin Medical?

When is the next results date for Dolphin Medical?

Why is Dolphin Medical falling/rising?

Compare Dolphin Medical with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

Returns Beta

News

When is the next results date for Dolphin Medical?

Announcements

Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended Ended September 30 2025

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ

Half Yearly Results Snapshot (Standalone) - Sep'25

Nine Monthly Results Snapshot (Standalone) - Mar'25

Annual Results Snapshot (Standalone) - Mar'25

About Dolphin Medical Services Ltd

Company Coordinates